PTMA

PTMA Full Name

prothymosin, alpha

PTMA Introduction

Prothymosin alpha (PTMA) is a highly conserved, small acidic nuclear protein that has gained increasing attention among researchers seeking to understand how cells maintain genomic integrity under stress. One of the most pressing challenges in cell biology and oncology is explaining why some cells efficiently recover from DNA damage while others accumulate mutations and progress toward disease. PTMA directly addresses this pain point by acting as a linker histone chaperone that regulates chromatin accessibility during DNA damage responses. Upon genotoxic stress, PTMA facilitates the rapid displacement of linker histone H1.0 from damaged chromatin regions, promoting local chromatin decondensation. This structural relaxation is essential for the timely recruitment of key repair factors such as PARP1, enabling efficient DNA repair. In the absence of PTMA, cells exhibit impaired recruitment of repair machinery and heightened sensitivity to DNA damage, highlighting its indispensable role in preserving genome stability and supporting cell survival under stress conditions.

Beyond its nuclear functions, PTMA also plays a critical role in extracellular signaling, addressing another major research challenge: how damaged or stressed cells communicate with the immune system. PTMA has been identified as an alarmin, a class of endogenous molecules that alert and activate immune responses following cellular injury. Unlike classical secreted proteins, PTMA is released through a non-vesicular pathway involving its interaction with Annexin-2 and a membrane "flop-out" mechanism. This unconventional release allows PTMA to rapidly enter the extracellular environment and function as a danger-associated molecular signal, modulating immune cell activation and inflammatory responses. This discovery provides important insight into sterile inflammation and immune surveillance, offering new opportunities for targeting PTMA-mediated pathways in inflammatory diseases and immunotherapy.

Importantly, dysregulation of PTMA is increasingly linked to complex diseases, particularly cancer and tissue injury, which remain major unmet clinical needs. In colorectal cancer, elevated PTMA expression has been associated with chemotherapy resistance, a critical barrier to effective treatment. Mechanistically, PTMA promotes metabolic reprogramming by inducing lipid droplet accumulation, enabling cancer cells to better withstand chemotherapeutic stress. At the same time, PTMA has demonstrated regenerative potential in ischemic injury models, where it cooperates with thymosin β4 to promote cardiomyocyte proliferation and improve cardiac repair. These seemingly distinct roles underscore PTMA's context-dependent functions in both disease progression and tissue recovery. Together, current evidence positions PTMA as a multifaceted molecular regulator at the intersection of chromatin dynamics, immune signaling, metabolism, and regeneration, making it a promising yet complex therapeutic target for future drug development.

Alternate Names for PTMA

prothymosin, alpha; OTTHUMP00000204428; TMSA; OTTHUMP00000204433; prothymosin, alpha (gene sequence 28); gene sequence 28; MGC104802; prothymosin alpha; OTTHUMP00000204425; prothymosin alpha protein; OTTHUMP00000204427; OTTHUMP00000204423; OTTHUMP00000204424

View more

• 1.McKnight CA, et al.; The linker histone chaperone Prothymosin α (PTMA) is essential for efficient DNA damage repair and the recruitment of PARP1. Epigenetics Chromatin. 2025, 18(1):32.
  2.Ueda H. Non-Vesicular Release of Alarmin Prothymosin α Complex Associated with Annexin-2 Flop-Out. Cells. 2023, 12(12):1569.